Page 80 - BH-2-3
P. 80

Brain & Heart                                                             Lipids in ALS: Bad and beneficial




                               A                               B














                               C                         D                        E


















            Figure 2. Interaction of the binding poses: (A) resveratrol and O60218, (B) resveratrol and P23280, (C) resveratrol and Q9H4B7, (D) resveratrol and
            Q9Y2D0, and (E) resveratrol and Q16236

                              A                                         B






















                             Figure 3. Interaction of the binding poses: (A) rotenone and P03905 and (B) rotenone and P33261
                                                                                            35
              Resveratrol, a polyphenol found in various plants,   prolonged the lifespan of ALS mice.  Furthermore, in the
            exhibits  potential  neuroprotective  activity  by  affecting   SOD1 G93A  mouse model of ALS, a resveratrol-enriched diet
            processes such as nuclear factor-kappa B (NF-κB)   demonstrated protective effects associated with increased
            activation  and  activator  protein-1  DNA  binding. 29,34   The   expression and activation of sirtuin 1 and AMPK in the
            administration of resveratrol has displayed protective   ventral spinal cord.  Delivery of resveratrol to the brain
                                                                               36
            effects on rat cortical motor neurons against the toxicity   through nanocarriers has been suggested to optimize its
            of CSF in ALS patients.  In addition, oral intake of   pharmacokinetics  and  effectiveness  in  preventing  and
                                 2
            resveratrol at 160 mg/kg/day improved motor abilities and   treating neurological disorders.  However, recent research
                                                                                        37
            Volume 2 Issue 3 (2024)                         9                                doi: 10.36922/bh.2976
   75   76   77   78   79   80   81   82   83   84   85